Skip to content

Shared Decision Making for Patients With First-admission Schizophrenia

Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01869660
Enrollment
23
Registered
2013-06-05
Start date
2013-06-30
Completion date
2015-10-31
Last updated
2015-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

First hospitalization

Brief summary

To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.

Interventions

BEHAVIORALShared Decision Making

The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.

Sponsors

Yokohama City University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Admitted to an acute care psychiatric ward. * Diagnosed with schizophrenia (ICD-10 codes: F20-F29) * Aged 16 to 65 years old at admission * No prior experience of psychiatric admission (first-admission)

Exclusion criteria

* Diagnosed with moderate to severe mental retardation * Diagnosed with organic mental disorders (ICD10 codes: F00-F09) * Having poor Japanese language skill * Severe conceptual disorganization as measured by brief psychiatric rating scale of 5 or more.

Design outcomes

Primary

MeasureTime frame
Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)Within 7days before the date of discharge

Secondary

MeasureTime frame
Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10)Within 7days before the date of discharge
Treatment continuation as measured by the rate of outpatient attendance during the 30 days6 months after discharge

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026